Xphyto Therapeutics Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020
XPhyto Therapeutics Corp. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was CAD 84,622 compared to CAD 45,072 a year ago. Operating loss was CAD 4.948 million compared to CAD 3.684 million a year ago. Net loss was CAD 6.801 million compared to CAD 3.731 million a year ago. Basic loss per share from continuing operations was CAD 0.11 compared to CAD 0.08 a year ago. For the nine months, sales was CAD 268,324 compared to CAD 45,072 a year ago. Operating loss was CAD 12.111 million compared to CAD 5.351 million a year ago. Net loss was CAD 14.082 million compared to CAD 5.477 million a year ago. Basic loss per share from continuing operations was CAD 0.25 compared to CAD 0.12 a year ago.